1. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
|
2. |
Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol, 2016, 22(44): 9694-9705.
|
3. |
Jutric Z, Melstrom LG. New treatment options and management considerations in borderline resectable pancreatic cancer. Oncology (Williston Park), 2017, 31(6): 443-452.
|
4. |
李仁涛, 李强. 胰十二指肠切除术中胰肠吻合的优化研究以及胰腺癌术后复发转移模式的多参数临床研究. 天津医科大学, 2019.
|
5. |
Dunn M, Morgan MB, Beer TW. Perineural invasion: identification, significance, and a standardized definition. Dermatol Surg, 2009, 35(2): 214-221.
|
6. |
Sakuta M. One hundred books which built up neurology (35)—Cruveilhier J “Anatomie Pathologique du Corps Humain” (1829-1842). Brain Nerve, 2009, 61(11): 1354-1355.
|
7. |
Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature. Cancer, 2009, 115(15): 3379-3391.
|
8. |
Chen SH, Zhang BY, Zhou B, et al. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. Am J Cancer Res, 2019, 9(1): 1-21.
|
9. |
Yang YH, Liu JB, Gui Y, et al. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer. World J Gastroenterol, 2017, 23(40): 7232-7241.
|
10. |
Chen JW, Bhandari M, Astill DS, et al. Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. HPB (Oxford), 2010, 12(2): 101-108.
|
11. |
Chatterjee D, Katz MH, Rashid A, et al. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol, 2012, 36(3): 409-417.
|
12. |
Deshmukh SD, Willmann JK, Jeffrey RB. Pathways of extrapancreatic perineural invasion by pancreatic adenocarcinoma: evaluation with 3D volume-rendered MDCT imaging. AJR Am J Roentgenol, 2010, 194(3): 668-674.
|
13. |
Makino I, Kitagawa H, Ohta T, et al. Nerve plexus invasion in pancreatic cancer: spread patterns on histopathologic and embryological analyses. Pancreas, 2008, 37(4): 358-365.
|
14. |
Kawarada Y. New classification of pancreatic carcinoma–Japan Pancreas Society. Nihon Shokakibyo Gakkai Zasshi, 2003, 100(8): 974-980.
|
15. |
Wang X, Zhang H, Wang T, et al. The concept and controversy of retroperitoneal nerve dissection in pancreatic head carcinoma (Review). Int J Oncol, 2015, 47(6): 2017-2027.
|
16. |
中国抗癌协会胰腺癌专业委员会. 胰腺癌综合诊治指南(2018 版). 中华外科杂志, 2018, 56(7): 481-494.
|
17. |
Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. Ann Surg Oncol, 2018, 25(4): 845-847.
|
18. |
中华医学会糖尿病学分会. 中国 2 型糖尿病防治指南(2017 年版). 中华糖尿病杂志, 2018, 10(1): 4-67.
|
19. |
Demir IE, Ceyhan GO, Liebl F, et al. Neural invasion in pancreatic cancer: the past, present and future. Cancers (Basel), 2010, 2(3): 1513-1527.
|
20. |
杨延辉, 张玉祥, 桂洋, 等. 胰腺癌与细胞自噬、神经浸润的关系. 临床肝胆病杂志, 2018, 34(11): 2475-2479.
|
21. |
Danigo A, Magy L, Demiot C. TRPV1 in neuropathic pain: from animal models to therapeutical prospects. Med Sci (Paris), 2013, 29(6-7): 597-606.
|
22. |
Gasparini G, Pellegatta M, Crippa S, et al. nerves and pancreatic cancer: new insights into a dangerous relationship. Cancers (Basel), 2019, 11(7): 893.
|
23. |
Rahn S, Zimmermann V, Viol F, et al. Diabetes as risk factor for pancreatic cancer: hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells. Cancer Lett, 2018, 415: 129-150.
|
24. |
Lin QJ, Yang F, Jin C, et al. Current status and progress of pancreatic cancer in China. World J Gastroenterol, 2015, 21(26): 7988-8003.
|
25. |
Ryu TY, Park J, Scherer PE. Hyperglycemia as a risk factor for cancer progression. Diabetes Metab J, 2014, 38(5): 330-336.
|
26. |
Yang J, Li X, Yang R, et al. Susceptibility-weighted imaging manifestations in the brain of Wilson’s disease patients. PLoS One, 2015, 10(4): e0125100.
|
27. |
Kazama S, Watanabe T. Diagnosis of colorectal cancer by measurement of tumor markers. Nihon Rinsho, 2014, 72(1): 71-76.
|
28. |
Goh SK, Gold G, Christophi C, et al. Serum carbohydrate antigen 19-9 in pancreatic adenocarcinoma: a mini review for surgeons. ANZ J Surg, 2017, 87(12): 987-992.
|
29. |
Shimada K, Nara S, Esaki M, et al. Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas. Pancreas, 2011, 40(3): 464-468.
|
30. |
Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene, 2002, 21(17): 2613-2622.
|
31. |
Rosenfeldt MT, O’Prey J, Morton JP, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature, 2013, 504(7479): 296-300.
|
32. |
陈汝福, 周泉波. 胰头癌行根治性胰十二指肠切除术神经清扫指征与技巧. 中国实用外科杂志, 2016, 36(8): 847-850.
|